Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Jones

Showing results (1-10 of 104) with videos related to

Pageof 11
Sort By:
Continuum (Minneapolis, Minn.)|June 5, 2016
Early Relapsing Multiple SclerosisDavid E Jones
Neurology. Clinical Practice|August 15, 2018
Disease-modifying therapies for nonrelapsing multiple sclerosis: Costs and benefits of medical interventionDavid E Jones
Gastroenterology & Hepatology|June 17, 2021
Practical Applications of Biochemistry Results in Primary Biliary CholangitisDavid E Jones
Digestive Diseases (Basel, Switzerland)|July 19, 2014
Pathogenesis of primary biliary cirrhosis and its fatigueLaura Griffiths, David E Jones
Therapeutic Advances in Gastroenterology|October 21, 2017
Novel strategies and therapeutic options for the management of primary biliary cholangitisAmardeep Khanna, David E Jones
Journal of Neurology|October 25, 2017
Correction to: The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerationsGabriel Pardo, David E Jones
Journal of Neurology|September 8, 2017
The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerationsGabriel Pardo, David E Jones
Expert Review of Clinical Immunology|August 23, 2014
Alemtuzumab for the treatment of relapsing-remitting multiple sclerosis: a review of its clinical pharmacology, efficacy and safetyDavid E Jones, Myla D Goldman
The New England Journal of Medicine|September 13, 2018
Bezafibrate in Primary Biliary CholangitisDavid E. Jones, Vinod S Hegade
Military Medicine|January 30, 2013
Traumatic event management in Afghanistan: a field report on combat applications in regional command-southDavid E Jones, Patricia Hammond, Kathy Platoni
Pageof 11

Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
Continuum (Minneapolis, Minn.)|June 5, 2016
Early Relapsing Multiple SclerosisDavid E Jones
Neurology. Clinical Practice|August 15, 2018
Disease-modifying therapies for nonrelapsing multiple sclerosis: Costs and benefits of medical interventionDavid E Jones
Gastroenterology & Hepatology|June 17, 2021
Practical Applications of Biochemistry Results in Primary Biliary CholangitisDavid E Jones
Digestive Diseases (Basel, Switzerland)|July 19, 2014
Pathogenesis of primary biliary cirrhosis and its fatigueLaura Griffiths, David E Jones
Therapeutic Advances in Gastroenterology|October 21, 2017
Novel strategies and therapeutic options for the management of primary biliary cholangitisAmardeep Khanna, David E Jones
Journal of Neurology|October 25, 2017
Correction to: The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerationsGabriel Pardo, David E Jones
Journal of Neurology|September 8, 2017
The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerationsGabriel Pardo, David E Jones
Expert Review of Clinical Immunology|August 23, 2014
Alemtuzumab for the treatment of relapsing-remitting multiple sclerosis: a review of its clinical pharmacology, efficacy and safetyDavid E Jones, Myla D Goldman
The New England Journal of Medicine|September 13, 2018
Bezafibrate in Primary Biliary CholangitisDavid E. Jones, Vinod S Hegade
Military Medicine|January 30, 2013
Traumatic event management in Afghanistan: a field report on combat applications in regional command-southDavid E Jones, Patricia Hammond, Kathy Platoni
Pageof 11